CHP announces two new confirmed melioidosis infection cases over past week
The Centre for Health Protection (CHP) of the Department of Health today (August 16) said that two new confirmed melioidosis infection cases had been recorded in the past week (August 9 to 15).
The first case involves a 91-year-old female with underlying illnesses who lives in Sham Shui Po. She developed a cough on July 7. She was admitted to Princess Margaret Hospital from July 21 to 24 due to a fall and pneumonia. She visited the Caritas Medical Centre on July 31 due to generalised weakness and was admitted on the same day. She is in stable condition. Her clinical sample was confirmed positive for Burkholderia pseudomallei upon testing.
The second case involves a 49-year-old male with underlying illnesses who lives in Southern District. He developed a cough, runny nose, sore throat, fever and chills starting August 4, and sought medical attention at Gleneagles Hospital on August 6, where he was diagnosed with a chronic disease. He then went to the Accident and Emergency Department of Queen Mary Hospital on August 7 and was admitted on the same day. His clinical sample was confirmed positive for Burkholderia pseudomallei upon testing. He is in stable condition.
The CHP is investigating the infection source of the cases. Epidemiological investigations are ongoing. So far, nine melioidosis infection cases have been recorded in Hong Kong this year. In 2023, 17 melioidosis infection cases were recorded.
A spokesman for the CHP reiterated that person-to-person transmission and animal-to-human transmission are rare, but melioidosis bacteria can survive in the local environment. Melioidosis is an endemic disease in Hong Kong and melioidosis cases have been recorded in Hong Kong each year. According to literature, infection cases are more common after typhoons or storms. The bacterium Burkholderia pseudomallei of melioidosis in soil and muddy water may become exposed to the ground after typhoons or storms, and the bacteria could spread more easily with strong winds or storms. As such, the number of melioidosis cases may increase.
The CHP reminded members of the public that melioidosis can be spread by contaminated soil and water during and after typhoons and storms. Where practicable, people should stay indoors during typhoons and storms, avoid travelling to areas with potential flooding, and refrain from wading in or coming into contact with muddy water and soil. In addition, high-risk individuals should avoid paths near stormwater drains where aerosols may be generated from contaminated water.
Members of the public should also take the following preventive measures against infection:
The CHP appealed to members of the public to seek medical advice if they develop symptoms, in particular people with diabetes or other immunocompromised conditions, in order to receive appropriate medical diagnosis and treatment. For more information on melioidosis, please visit the website of the CHP atwww.chp.gov.hk/en/healthtopics/content/24/101110.html.
Source: AI-generated images
DH signs Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines with Experimental Research Center of the China Academy of Chinese Medical Sciences to promote implementation of innovation and high-quality development of traditional Chinese medicine
The Director of Health, Dr Ronald Lam, today (September 11) witnessed in Beijing the Department of Health (DH) and the Experimental Research Center (ERC) of the China Academy of Chinese Medical Sciences (CACMS), which is a subsidiary organisation under the National Administration of Traditional Chinese Medicine (NATCM), signing a Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines (Co-operation Agreement) that covers a period of five years. The Co-operation Agreement reinforces the exchange and collaboration, jointly promote the modernisation and innovation of Chinese medicines, as well as the advancement of high-quality development of Chinese medicines.
Witnessed by Dr Ronald Lam, Director of the Department of International Co-operation (Office of Hong Kong, Macao & Taiwan Affairs) of the NATCM, Mr Wu Zhendou, and the Vice President of the CACMS, Dr Yang Hongjun, the Co-operation Agreement was signed by the Assistant Director of Health (Chinese Medicine), Dr Edmund Fong, and the Deputy Director of the ERC, Dr Yuan Yuan.
The areas of collaboration include reinforcement on research and standardization of Chinese medicines quality testing, establishment of Chinese medicines quality testing data platforms, holding expert meetings on different fields of Chinese medicines jointly. The Co-operation Agreement enhances the standard of local Chinese medicines testing technology, reinforces the exchange and collaboration on testing technology, nurtures innovative talents and further foster the internationalisation of Chinese medicines, so as to align with the national development strategies for Chinese medicines as outlined in the Development Plan for Traditional Chinese Medicine during the 14th Five-Year Plan Period.
"I would like to express my heartfelt gratitude to the NATCM and the CACMS for their continuous support to the DH, including sending Chinese medicine experts to join Hong Kong to combat the COVID-19 pandemic, arranging acupuncture experts to provide guidance and training for local Chinese medicine practitioners on smoking cessation services with the Chinese medicine and acupuncture, sending Chinese medicine experts to assist Hong Kong Special Administrative Region (HKSAR) in conducting the Chinese Medicine Practitioners Licensing Examination, and inviting HKSAR Government to participate in the 'the Fourth National Survey of Chinese Materia Medica Resources' and providing guidance in various technical aspects. We have maintained close collaboration on the inheritance and innovation of Chinese medicine and to the development of global health over the years. I earnestly look forward to deepening our co-operation and exchange in Chinese medicine through the Co-operation Agreement signed today, and continue to work together to build a healthy China, healthy Greater Bay Area, and a healthy Hong Kong!", Dr Lam said.
After the signing ceremony, Dr Lam visited the ERC and the National Resource Center for Chinese Materia Medica of the CACMS, to learn about the latest development of Chinese medicines testing and research work in the Mainland and had discussion with professional staff in the laboratories. Dr Lam stated that upon the completion and commissioning of the new building of the Government Chinese Medicines Testing Institute, there will be more opportunities for both parties to collaborate on Chinese medicines research, allowing more research results to be published in the new journal Science of Traditional Chinese Medicine.
The DH has been actively facilitating exchange and co-operation with the NATCM in the testing and reference standard research of Chinese medicines. Both parties will implement the work related to promoting the high-quality development of the traditional Chinese medicines industry as outlined in the Development Plan for Traditional Chinese Medicine during the 14th Five-Year Plan Period, including the joint construction of a quality testing platform for Chinese medicines, and accelerating the standardisation, informatisation, modernisation and internationalisation of Chinese medicines. Under this synergistic effect, it can further promote the Chinese medicines industry towards high-quality development.
DH signs Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines with Experimental Research Center of the China Academy of Chinese Medical Sciences to promote implementation of innovation and high-quality development of traditional Chinese medicine Source: HKSAR Government Press Releases
DH signs Co-operation Arrangement on Research for Quality Testing and Standards of Chinese Medicines with Experimental Research Center of the China Academy of Chinese Medical Sciences to promote implementation of innovation and high-quality development of traditional Chinese medicine Source: HKSAR Government Press Releases
